Epigenetic markers predict complications in patients with type 2 diabetes
Charlotte Ling and her research group have studied DNA methylations in the genome of different patient groups with type 2 diabetes. Photo: Kennet Ruona A new study by researchers at Lund University supports the notion that patients with type 2 diabetes should be divided into subgroups and given individualised treatment. The study demonstrates that there are distinct epigenetic differences between
https://www.ludc.lu.se/article/epigenetic-markers-predict-complications-patients-type-2-diabetes - 2025-08-27